Skip to main content
. 2016 Apr 19;100:4773–4778. doi: 10.1007/s00253-016-7500-1

Scheme 6.

Scheme 6

Ene-reductase-catalyzed asymmetric hydrogenation that could lead to an additional two side products due to the presence of ADHs, which are not active when using a biomimetic as the cofactor